KSL Management Team
KEVIN LAWSON
Partner
Kevin is an accomplished biotechnology executive with formidable experience identifying and building value in promising new technologies through collaborative licensing and internal basic research. Working closely with regulatory authorities at all levels: departments of health, FDA and international bodies, he has driven development, regulatory clearance and commercialization of numerous novel reference laboratory tests and IVDs in the US and rest of world. He is responsible for validation and approval of many LDTs and 510k of more than 50 assays and medical devices.
LAKSHMANAN SURESH, DDS, MS, PhD. (D) ABOMP, (D) ABMLI
Partner
Dr. Suresh is a Clinical Professor at the State University of New York at Buffalo. He completed his PhD in computational cell biology, anatomy and pathology, MS in Oral biological sciences and specialty training in Oral and Maxillofacial Pathology all from the University at Buffalo, State University of New York. Dr. Suresh has over 25 years of experience in pathology and laboratory medicine. He is board-certified in Oral and Maxillofacial Pathology by the American Board of Oral and Maxillofacial Pathology and American Board of Medical Laboratory Immunology. He has authored numerous publications and book chapters, holds several patents and maintains various research collaborations with investigators throughout the World.
LONG SHEN, PhD
Partner
Dr. Long Shen is a founding partner of KSL Biomedical. Drawing upon scientific and medical training in Xiamen University, China and The University at Buffalo, USA, he has performed as translational biomedical research innovative scientific program leader for over 15 years in academic programs and private industry. Dr. Shen has made significant contributions to the identification of novel biomarkers for the early diagnosis of autoimmune disease and associated B-cell lymphomas. Dr. Shen has authored more than 25 peer-reviewed publications in high impact research journals and is co-inventor on a number patents in this field.
Vince Ramsperger, MS
R&D Manager
Vince is an experienced immunoassay developer that has worked in the fields of autoimmunology and infectious diseases for more than 25 years. He has worked in R&D, manufacturing, QC, QA, and regulatory affairs. Specializing in immunoassay development and regulatory submissions, Vince has more than 50 FDA 510k approvals and 15 New York State LDT approvals. He has experience with ELISA, CLIA, IFA, Agglutination, Western Blot, LIA immunoassays, and has led multiple FDA submission meetings. Vince and his highly-skilled R&D team are the right people to take an assay from feasibility through validation, regulatory approval, and manufacturing scaleup.